DISEASE-MODIFYING THERAPY
Mayzent (siponimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in adults.
These insights are based on 1,079 comments about Mayzent from MyMSTeam members. These are the experiences of a small number of people and are not meant to be medical advice.
Mayzent works by attaching to certain signals on immune cells. These signals are called S1P receptors. This keeps some immune cells in the lymph nodes and lowers the number in the blood. The exact way Mayzent helps multiple sclerosis is not fully known. It may help by reducing immune cells that enter the brain and spinal cord.
Doctors prescribe Mayzent when an adult has a relapsing form of multiple sclerosis. The medication is given as a tablet taken by mouth once a day. Treatment starts with a step-up schedule over four or five days before moving to a daily dose.
Members who use Mayzent often say the most helpful steps are staying in close contact with their neurology team, keeping up with required testing, and paying attention to side effects early. Many also mention practical issues like the starter pack, insurance approvals, and patient assistance as important parts of getting started and staying on treatment.
Get the recommended tests before starting.
“My neurologist had me get the Shingrix, Prevnar 20, and meningitis A and B vaccines before I started Mayzent. I also had the recommended ECG, and saw my eye doc to test for macular degeneration.”
Keep track of side effects and tell your doctor.
“I was on Mayzent for six months but stopped using it because it drove my blood pressure up to crazy high numbers. I know this because I monitor mine weekly due to my family history.”
Ask about cost help and pharmacy support early.
“With the copay program, I have not had to pay anything so far.”
Connect with others who understand life with multiple sclerosis. Join MyMSTeam for free.
In clinical studies of Mayzent for relapsing forms of multiple sclerosis in adults, the most common side effects occurred in between 11 percent and 15 percent of people. These side effects included:
Mayzent can cause serious side effects that require immediate medical attention. These include:
Get medical help right away if you think you are having a serious reaction.
Novartis Pharmaceuticals, the manufacturer of Mayzent, offers the Novartis Patient Support program. Commercially insured patients may pay as little as $0 in copay.
The Novartis Patient Support program also offers support and resources. To learn more, visit the Novartis website or call 877-629-9368.
Before starting Mayzent, your doctor may perform:
Your doctor will test you for antibodies to varicella zoster virus (VZV). If you are not immune, you should get the VZV vaccine before starting Mayzent. Avoid live vaccines during treatment and for four weeks after stopping Mayzent.
Tell your doctor if you have any allergies to siponimod or any ingredients in Mayzent.
Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
Also let your doctor know if you have had recent infections, plan to travel to areas where certain infections are common, or have had cancer or nervous system problems in the past.
Do not take Mayzent if you have a CYP2C9*3/*3 genotype, certain serious heart problems in the past six months, or certain heart rhythm conditions unless you have a pacemaker.
If you miss a dose during the starting schedule for more than 24 hours, you need to restart from day 1. If you miss four or more days in a row after starting daily treatment, you also need to restart from day 1.
If you are pregnant, planning to become pregnant, or breastfeeding while taking Mayzent, talk with your doctor about the risks and benefits. Mayzent may harm an unborn baby. People who can become pregnant should use birth control during treatment and for 10 days after stopping Mayzent.
These answers are fact-checked by our editorial staff.
How effective is Mayzent?
In a study of 1,651 people with secondary progressive multiple sclerosis, 26 percent of people taking Mayzent got worse over time, compared to 32 percent of people taking a placebo (an inactive treatment). This means a 21 percent lower relative risk and a 6 percent lower absolute risk. Mayzent also lowered the number of relapses by 55 percent compared with placebo. It did not significantly delay worsening on the timed 25-foot walk test. The benefit was not clearly shown in people with nonactive disease.
What tests are needed before starting Mayzent for multiple sclerosis?
Before starting Mayzent, your doctor will check your CYP2C9 genotype, heart rhythm with an ECG, blood counts, and liver tests. You will also need an eye exam that looks at the back of the eye and a skin exam. Your doctor will test for varicella zoster virus antibodies and may recommend vaccination before treatment if needed.
What should I do if I miss a dose of Mayzent for multiple sclerosis?
If you miss one or more titration doses for more than 24 hours, you need to restart from day 1. If you miss four or more days in a row after starting daily treatment, you also need to restart from day 1. Take the tablets whole. You can take them with or without food.
Does Mayzent for multiple sclerosis raise the risk of infections?
Yes. Mayzent lowers certain white blood cells to about 20 percent to 30 percent of normal levels, which can increase the risk of infections. Some infections can be serious. In studies, overall infection rates were similar to placebo, but some infections like herpes, bronchitis, sinus infections, and fungal skin infections were more common. Avoid live vaccines during treatment and for four weeks after stopping. Vaccines may work less well during treatment and for up to one month after stopping.
On MyMSTeam, people share their experiences with multiple sclerosis, get advice, and find support from others who understand.
Learn more about Mayzent and multiple sclerosis care:
More resources from MyMSTeam that mention Mayzent
Become a member to get even more